111, Inc. (NASDAQ:YI) Short Interest Update

111, Inc. (NASDAQ:YI) was the recipient of a large drop in short interest in February. As of February 15th, there was short interest totalling 6,100 shares, a drop of 74.3% from the January 31st total of 23,700 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average daily trading volume, of 34,900 shares, the short-interest ratio is currently 0.2 days.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of 111 in a research report on Wednesday, February 19th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its stake in shares of 111 by 43,619.9% in the 4th quarter. JPMorgan Chase & Co. now owns 306,039 shares of the company’s stock worth $191,000 after acquiring an additional 305,339 shares during the last quarter. Napean Trading & Investment Co Singapore PTE Ltd acquired a new stake in shares of 111 in the 4th quarter worth $245,000. Finally, FIL Ltd acquired a new stake in shares of 111 in the 4th quarter worth $450,000. Hedge funds and other institutional investors own 21.32% of the company’s stock.

111 Price Performance

Shares of NASDAQ:YI opened at $8.85 on Friday. 111 has a 1 year low of $4.14 and a 1 year high of $15.80. The firm has a market capitalization of $75.69 million, a price-to-earnings ratio of -2.21 and a beta of 0.41. The business’s 50 day moving average price is $6.45 and its 200-day moving average price is $7.34.

111 (NASDAQ:YI) last announced its earnings results on Wednesday, November 27th. The company reported ($0.20) earnings per share (EPS) for the quarter.

About 111

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.